Skip to main content

Table 1 Demographics and clinical parameters of the study patients

From: Effects of ciprofol on respiratory-related adverse incidence in patients with obesity during painless gastroscopy: a prospective, randomized clinical trial

 

Group C

(n = 40)

Group P

(n = 40)

P-value

Age (years)

44.5 ± 8.0

48.0 ± 9.8

0.087

Sex, n (%)

  

/

 Female

14 (35.0)

14 (35.0)

 

 Male

26 (65.0)

26 (65.0)

 

 Weight (kg)

82.3 ± 8.4

84.4 ± 8.3

0.265

Height (m)

1.7 ± 0.1

1.7 ± 0.1

0.549

BMI (kg/m2)

29.8 ± 1.6

30.2 ± 1.5

0.298

ASA PS, n (%)

  

0.366

 I

19 (47.5)

15 (37.5)

 

 II

21 (52.5)

25 (62.5)

 

STOP-Bang score

2.6 ± 1.1

2.9 ± 1.4

0.208

HBP history, n (%)

6 (15.0)

7 (17.5)

0.762

Duration of operation (min)

6.3 ± 1.9

6.1 ± 2.5

0.611

  1. Data are provided as the mean ± standard deviation, or number (%)
  2. BMI body mass index, ASA American Society of Anesthesiologists Physical Status, HBP high blood pressure